EUVIMEDEUVIMED entdecken
Open Access

The Impact of Lung and Heart Radiation Dose during Preoperative Chemoradiation on Overall Survival in Esophageal Cancer – A Post Hoc Analysis of CALGB 80803 (Alliance)

Eric J Lehrer, Susan Geyer, Austin Goodrich, Lauren E Haydu, David Ilson, Vishruta Dumane, Anne Noonan, Karyn A Goodman

International Journal of Radiation Oncology*Biology*Physics · 2026

DOI: 10.1016/j.ijrobp.2026.01.032 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2026. Verfasst von Eric J Lehrer und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota; Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New Y…. Hauptthemen laut MEDLINE: Heart, Radiotherapy, Intensity-Modulated, Lung, Esophageal Neoplasms. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Cancer Institute, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Although technical advances have allowed for reduced radiation doses to the lungs and heart when treating esophageal cancer, doses to these organs cannot yet be eliminated completely. We conducted a post hoc analysis of CALGB 80803 (Alliance) to evaluate whether the radiation doses delivered to the heart and lungs in a prospective study with robust quality assurance were associated with overall survival (OS), and we assessed the impact of intensity modulated radiation therapy (IMRT) on adherence with protocol-specified dose constraints. METHODS AND MATERIALS: Protocol-specified dose constraints were based on standard of care guidelines: total lung V10 Gy ≤ 40%, V20 Gy ≤ 20%, V30 Gy ≤ 15%, V40 Gy ≤ 10%; heart V30 Gy ≤ 30%. Post hoc dose cutpoints were calculated that best differentiated OS. RESULTS: A total of 225 patients underwent induction chemotherapy, where radiation modality data were available for 209/225 (92.8%); 127/209 (60.9%) were treated with IMRT. Adherence rates were high for each of the protocol-specified dose constraints: 162/209 (77.5%), 179/209 (85.6%), 207/209 (99.0%), 208/209 (99.5%), and 158/209 (75.6%); total lung: V10 Gy, V20 Gy, V30 Gy, V40 Gy, and heart V30 Gy, respectively. The heart V30 Gy ≤ 21% (P = .016) was associated with improved OS. Among patients with heart V30 Gy ≤ 21%, 8.5% and 32.3% received 3-dimensional conformal radiation therapy (3D-CRT) and IMRT, respectively (P 42% (hazard ratio [HR], 1.71; P = .017) and heart V30 Gy > 21% (HR, 1.86; P = .013) were associated with worse OS. CONCLUSIONS: Most patients on CALGB 80803 (Alliance) were treated with IMRT plans that met protocol-specified dose constraints for total lung and heart. Minimizing low dose volume to the lungs (V10 Gy) and minimizing heart V30 Gy were associated with a significant survival benefit. Total lung V10 Gy ≤ 42% and heart V30 Gy ≤ 21%, and utilization of IMRT over 3D-CRT, should be considered when designing radiation plans for patients with esophageal cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HeartRadiotherapy, Intensity-ModulatedLungEsophageal NeoplasmsChemoradiotherapyOrgans at RiskHumansRadiotherapy DosageFemaleMiddle AgedMaleProspective StudiesAgedInduction Chemotherapy

Autor:innen und Institutionen

  • Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota; Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, Minnesota.
  • Department of Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Department of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio.
  • Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, New York. Electronic address: karyn.goodman@mountsinai.org.

Förderung

  • NCI NIH HHS
  • National Cancer Institute
  • National Institutes of Health

Zitieren

APA

Lehrer, E. J., Geyer, S., Goodrich, A., Haydu, L. E., Ilson, D., Dumane, V., Noonan, A., & Goodman, K. A. (2026). The Impact of Lung and Heart Radiation Dose during Preoperative Chemoradiation on Overall Survival in Esophageal Cancer – A Post Hoc Analysis of CALGB 80803 (Alliance). International Journal of Radiation Oncology*Biology*Physics. https://doi.org/10.1016/j.ijrobp.2026.01.032

Vancouver

Lehrer EJ, Geyer S, Goodrich A, Haydu LE, Ilson D, Dumane V, et al. The Impact of Lung and Heart Radiation Dose during Preoperative Chemoradiation on Overall Survival in Esophageal Cancer – A Post Hoc Analysis of CALGB 80803 (Alliance). International Journal of Radiation Oncology*Biology*Physics. 2026. doi:10.1016/j.ijrobp.2026.01.032

BibTeX
@article{Lehrer2026,
  author = {Lehrer, Eric J and Geyer, Susan and Goodrich, Austin and Haydu, Lauren E and Ilson, David and Dumane, Vishruta and Noonan, Anne and Goodman, Karyn A},
  title = {The Impact of Lung and Heart Radiation Dose during Preoperative Chemoradiation on Overall Survival in Esophageal Cancer – A Post Hoc Analysis of CALGB 80803 (Alliance)},
  journal = {International Journal of Radiation Oncology*Biology*Physics},
  year = {2026},
  doi = {10.1016/j.ijrobp.2026.01.032}
}
Kostenlos starten →